申请人:C4 Therapeutics, Inc.
公开号:US10646575B2
公开(公告)日:2020-05-12
This invention provides heterocyclic compounds that bind to E3 Ubiquitin Ligase (typically through cereblon) (“Degrons”), which can be used as is or linked to a Targeting Ligand for a selected Target Protein for therapeutic purposes and methods of use and compositions thereof as well as methods for their preparation.
本发明提供了能与 E3 泛素连接酶(通常是通过脑龙)("Degrons")结合的杂环化合物,这些杂环化合物可用于治疗目的或与选定靶蛋白的靶向配体相连接,并提供了其使用方法和组合物及其制备方法。